DK0876398T3 - Induktion af immunrespons med ønskede determinanter - Google Patents

Induktion af immunrespons med ønskede determinanter

Info

Publication number
DK0876398T3
DK0876398T3 DK97902074T DK97902074T DK0876398T3 DK 0876398 T3 DK0876398 T3 DK 0876398T3 DK 97902074 T DK97902074 T DK 97902074T DK 97902074 T DK97902074 T DK 97902074T DK 0876398 T3 DK0876398 T3 DK 0876398T3
Authority
DK
Denmark
Prior art keywords
immune response
induction
determinants
desired determinants
provides compositions
Prior art date
Application number
DK97902074T
Other languages
Danish (da)
English (en)
Inventor
Jeffery L Alexander
Shawn Defrees
Alessandro Sette
Original Assignee
Epimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epimmune Inc filed Critical Epimmune Inc
Application granted granted Critical
Publication of DK0876398T3 publication Critical patent/DK0876398T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/605—MHC molecules or ligands thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Control Of High-Frequency Heating Circuits (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK97902074T 1996-01-24 1997-01-23 Induktion af immunrespons med ønskede determinanter DK0876398T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1051096P 1996-01-24 1996-01-24
PCT/US1997/001041 WO1997026784A1 (en) 1996-01-24 1997-01-23 Induction of immune response against desired determinants

Publications (1)

Publication Number Publication Date
DK0876398T3 true DK0876398T3 (da) 2002-08-12

Family

ID=21746084

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97902074T DK0876398T3 (da) 1996-01-24 1997-01-23 Induktion af immunrespons med ønskede determinanter

Country Status (12)

Country Link
EP (1) EP0876398B1 (ja)
JP (1) JP4063879B2 (ja)
CN (1) CN1214051A (ja)
AT (1) ATE220687T1 (ja)
AU (1) AU1582797A (ja)
BR (1) BR9710404A (ja)
CA (1) CA2242878C (ja)
DE (1) DE69714011T2 (ja)
DK (1) DK0876398T3 (ja)
ES (1) ES2177927T3 (ja)
PT (1) PT876398E (ja)
WO (1) WO1997026784A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528061B1 (en) * 1997-09-04 2003-03-04 Pasteur Institut Immunogenic polypeptides that mimic a surface polysaccharide antigen of a pathogenic microorganism, method for obtaining the same, and their use in vaccine compositions
EP1903056A3 (en) 2002-12-10 2008-05-07 Idm Pharma, Inc. HLA-A1, -A2 -A3, -A24, -B7, and -B44 binding peptides comprising tumor associated antigen epitopes, and compositions thereof
AU2003285280A1 (en) * 2002-12-11 2004-06-30 Pharmexa A/S Targeting single epitopes
US20080274129A1 (en) 2003-04-18 2008-11-06 Fikes John D Hla-A2 Tumor Associated Antigen Peptides and Compositions
ES2310072B1 (es) 2005-12-23 2009-11-16 Proyecto De Biomedicina Cima, S.L. Nuevos peptidos determinantes antigenicos t colaboradores (/dth).
WO2009025777A1 (en) * 2007-08-17 2009-02-26 University Of Maryland Carbohydrate functionalized catanionic surfactant vesicles for drug delivery
US9249187B2 (en) 2009-01-28 2016-02-02 Epimmune Inc. Pan-DR binding polypeptides and uses thereof
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
US10588952B2 (en) * 2013-03-29 2020-03-17 Sumitomo Dainippon Pharma Co., Ltd. Conjugate vaccine using trimming function of ERAP1
ES2691091T3 (es) 2013-03-29 2018-11-23 Sumitomo Dainippon Pharma Co., Ltd. Vacuna conjugada de péptido antigénico de WT1
CA2919835A1 (en) 2013-07-31 2015-02-05 Board Of Trustees Of The University Of Arkansas Compositions for and methods of treating and preventing cancer targeting tumor associated carbohydrate antigens
CN106456766B (zh) * 2014-03-19 2020-03-10 台湾基督长老教会马偕医疗财团法人马偕纪念医院 抗免疫原性糖肽的抗体、包含其的组合物及其用途
CN107141355B (zh) * 2017-05-31 2021-05-14 中国人民解放军第四军医大学 一种htnv抗原表位线性串联多肽及表位肽-复合物四聚体和应用
CN109991422A (zh) * 2017-12-29 2019-07-09 复旦大学 基于特异抗血清的棕榈酰化修饰蛋白质的检测方法
US20230181721A1 (en) 2020-05-11 2023-06-15 Ose Immunotherapeutics Vaccine against sars-cov virus
AU2021311894A1 (en) 2020-07-22 2023-02-02 3H Bio. Co., Ltd. Peptide for immunotherapeutic agent
KR102261457B1 (ko) * 2020-07-22 2021-06-09 (주)쓰리에이치바이오 면역 치료제용 펩타이드
WO2022268916A2 (en) 2021-06-23 2022-12-29 Ose Immunotherapeutics Pan-coronavirus peptide vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2157510A1 (en) * 1993-03-05 1994-09-15 Howard M. Grey Hla-a2.1 binding peptides and their uses
JP3926839B2 (ja) * 1993-09-14 2007-06-06 エピミューン，インコーポレイティド 万能ｄｒ−結合性ペプチドを用いる免疫応答の改変

Also Published As

Publication number Publication date
PT876398E (pt) 2002-12-31
ATE220687T1 (de) 2002-08-15
CN1214051A (zh) 1999-04-14
CA2242878A1 (en) 1997-07-31
AU1582797A (en) 1997-08-20
DE69714011D1 (de) 2002-08-22
EP0876398A1 (en) 1998-11-11
BR9710404A (pt) 1999-08-17
WO1997026784A1 (en) 1997-07-31
CA2242878C (en) 2010-06-22
JP4063879B2 (ja) 2008-03-19
JP2000504328A (ja) 2000-04-11
EP0876398B1 (en) 2002-07-17
DE69714011T2 (de) 2003-02-27
ES2177927T3 (es) 2002-12-16

Similar Documents

Publication Publication Date Title
DK0876398T3 (da) Induktion af immunrespons med ønskede determinanter
EP1545597A4 (en) IMMUNOSTIMULANT COMPOSITIONS AND METHODS FOR STIMULATING AN IMMUNE RESPONSE
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
NO933126D0 (no) Loeselige ligander for cd40
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
BE2012C001I2 (ja)
NZ508110A (en) Attenuated mutants of salmonella which constitutively express the Vi antigen
ATE546153T1 (de) Kombinationen von tumor-assoziierten antigenen zur behandlung von verschiedenen krebstypen
EA199900069A1 (ru) Вакцинная композиция против малярии
FR2721811B1 (fr) Fauteuil de relaxation
NO964238L (no) Halofantrin-fri-base for behandling av malaria og blandinger
DK0786004T3 (da) Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
DE69723580D1 (de) Impfstoff gegen metastasierenden kolorektalkrebs.
TR200200278T2 (tr) Kalsilitik bileşimler
FR2715304B1 (fr) Vaccin anti-allergique.
BG103543A (en) The use of pramipexol in the treatment of the uneasy legs syndrome
NO20005548D0 (no) Mykobakterieinhibitorer
DE69110088D1 (de) Hitzebeständiger Klebstoff und diesen anwendendes Klebeverfahren.
ITFI930209A1 (it) Dispositivo di riscaldamento per elettrodomestici e procedimento per la fabbricazione di esso.
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
DE60128374D1 (de) Varianten des hauptallergen par j 2 von parietaria judaica
EP1555316A3 (en) Antigen library immunization
ITRM940133A0 (it) Dispositivo riscaldatore e sterilizzatore rapido ad induzione elettromagnetica di alta frequenza, per attrezzi di odontotecnica odontoiatria, microchirurgica, estetica e simili.
ITPC20020008A1 (it) Mezzi per il supporto ed il trattamento di resistenze elettriche in particolare per tostapane od apparecchi di riscaldamento similari.
UA36540A (uk) Спосіб проведення кліматооздоровчих процедур з використанням галотерапії та установка для його здійснення